Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 17 studies | 35% ± 18% | |
| oligodendrocyte precursor cell | 17 studies | 56% ± 24% | |
| GABAergic neuron | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 13086.87 | 2638 / 2642 | 99% | 2263.67 | 701 / 705 |
| eye | 0% | 0 | 0 / 0 | 99% | 139.76 | 79 / 80 |
| skin | 18% | 296.79 | 323 / 1809 | 70% | 187.93 | 332 / 472 |
| adrenal gland | 12% | 276.43 | 31 / 258 | 48% | 21.67 | 110 / 230 |
| uterus | 15% | 258.56 | 25 / 170 | 4% | 0.91 | 18 / 459 |
| liver | 0% | 0 | 0 / 226 | 8% | 1.23 | 33 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 5.56 | 3 / 45 |
| esophagus | 0% | 0 | 0 / 1445 | 7% | 0.80 | 12 / 183 |
| stomach | 3% | 37.96 | 12 / 359 | 2% | 0.18 | 7 / 286 |
| lung | 0% | 0 | 0 / 578 | 4% | 0.85 | 51 / 1155 |
| breast | 0% | 0 | 0 / 459 | 4% | 0.93 | 44 / 1118 |
| kidney | 0% | 0 | 0 / 89 | 4% | 1.38 | 35 / 901 |
| intestine | 1% | 19.43 | 13 / 966 | 2% | 0.17 | 13 / 527 |
| pancreas | 0% | 0 | 0 / 328 | 3% | 0.85 | 6 / 178 |
| ovary | 0% | 0 | 0 / 180 | 3% | 0.95 | 14 / 430 |
| thymus | 0% | 16.36 | 2 / 653 | 1% | 0.48 | 5 / 605 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.38 | 5 / 504 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0.03 | 2 / 502 |
| heart | 0% | 1.24 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
| GO_0001501 | Biological process | skeletal system development |
| GO_0010001 | Biological process | glial cell differentiation |
| GO_0021766 | Biological process | hippocampus development |
| GO_0007155 | Biological process | cell adhesion |
| GO_0060074 | Biological process | synapse maturation |
| GO_0007417 | Biological process | central nervous system development |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0098552 | Cellular component | side of membrane |
| GO_0045202 | Cellular component | synapse |
| GO_0005576 | Cellular component | extracellular region |
| GO_0072534 | Cellular component | perineuronal net |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| Gene name | BCAN |
| Protein name | Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7) Brevican core protein Brevican Alternative protein BCAN |
| Synonyms | CSPG7 UNQ2525/PRO6018 BEHAB |
| Description | FUNCTION: May play a role in the terminally differentiating and the adult nervous system during postnatal development. Could stabilize interactions between hyaluronan (HA) and brain proteoglycans. |
| Accessions | ENST00000457777.6 ENST00000361588.5 [Q96GW7-2] ENST00000491823.1 ENST00000479949.5 Q5T3I8 V9GY88 Q5T3I6 L8E931 ENST00000424639.5 ENST00000329117.10 [Q96GW7-1] Q5T3I7 Q96GW7 V9GXZ8 ENST00000441358.5 |